The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cetuximab observational study as first-line therapy in patients with metastatic colorectal cancer.
 
Michio Itabashi
Honoraria - Chugai Pharma
Research Funding - Chugai Pharma (Inst)
 
Kimitaka Tani
No Relationships to Disclose
 
Kei Muro
Honoraria - Chugai Pharma; Takeda; Yakult Honsha
Consulting or Advisory Role - Takeda
 
Toshiki Masuishi
No Relationships to Disclose
 
Yasuo Ohashi
Stock and Other Ownership Interests - Saatcom Co.
Honoraria - Sanofi
Consulting or Advisory Role - Chugai Pharma; Eisai; Shionogi; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Takeda; Yakult Honsha
 
Kenichi Sugihara
Honoraria - Chugai Pharma; Merck Serono
Research Funding - Chugai Pharma (Inst)